Trials / Sponsors / ApcinteX Ltd
ApcinteX Ltd
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | The Long-term Safety and Efficacy of SerpinPC in Subjects with Hemophilia Who Completed a Sponsored SerpinPC C Hemophilia a, Hemophilia B, Hemophilia a with Inhibitor | Phase 3 | 2024-07-11 |
| Terminated | A Study of SerpinPC in Participants with Hemophilia B (HemB) with Inhibitors Hemophilia B with Inhibitor, Hemophilia B | Phase 2 | 2023-07-28 |
| Terminated | The Efficacy and Safety of SerpinPC in Participants with Severe Hemophilia a or Moderately Severe to Severe He Hemophilia a, Hemophilia B | Phase 2 | 2023-07-06 |
| Terminated | Hemophilia Non-Interventional Study Prior to SerpinPC Intervention (PRESent-5) Hemophilia a, Hemophilia B | — | 2022-12-09 |
| Completed | The Safety and Tolerability of SerpinPC in Healthy Men and in Men with Severe Blood Disorders (haemophilia a a Hemophilia a, Hemophilia B | Phase 1 / Phase 2 | 2019-08-14 |